Nifty 50 index concluded 0.04 per cent lower at 19,794, while the Sensex closed with 0.07 per cent loss at 65,970, , stock market, nifty, sensex, it stocks, pharma stocks, retail investors, Intraday, national stock exchange, Honasa Consumer, life insurance, defence stocks
According to a CNBC-TV18, the warning letter has underlined data integrity issues at Cipla embedded with product complaints and microbial contamination
The Natco Pharma stock has given a return of 26.22 percent over the last six months. The benchmark Nifty50 index has given a return of 5.68 percent over the same duration.
PDS, which acts as a link between retailers & brands in the West and small garment manufacturers in the Far East, has seen its share prices grow around 65% so far in the calendar year.
“Pharma sector can be a very good proxy to a weak rupee. Rather than IT, be in pharma to play a weak rupee. That has been a splendid outperforming sector. Cipla, Sun Pharma, Aurobindo are just coming of age and I still continue to think Lupin can be a huge outperformer.”